Pancreatic Cancer | Tumor

CURE’s pancreatic cancer page features the latest cancer news and updates on pancreatic cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in pancreatic cancer.

Writing Helped Me Heal After Pancreatic Cancer

July 17th 2025, 5:00pm

Article

Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a powerful path to healing.

Daraxonrasib Gains FDA Status for Certain Metastatic Pancreatic Cancer

June 24th 2025, 3:00pm

Article

Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic pancreatic ductal adenocarcinoma.

Spotlighting Pancreatic Cancer Disparities in Black Communities

June 23rd 2025, 4:14pm

Article

Tripp Razor highlights the disproportionately high pancreatic cancer risk among Black Americans and the systemic disparities they face in access to care.

Atebimetinib Combo Shows 94% 6-Month Survival in Pancreatic Cancer

June 18th 2025, 3:00pm

Article

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses and a favorable safety profile.

Pancreatic Cancer Tried to Crash My Three Daughters’ Weddings

June 13th 2025, 5:00pm

Article

I was told I wouldn’t live to see my daughters’ weddings — but 12 years later, I’ve been there for two, and I’m holding out hope for the third.

A Trailblazer in Oncology Nursing and Research

May 21st 2025, 9:00pm

Article

Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, is a trailblazer whose expertise and compassion have made a profound impact on oncology care.

2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.

May 16th 2025, 8:28pm

Article

Enclosed is the 2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.

Eraglusib Combo Improves Survival in Metastatic Pancreatic Cancer

May 9th 2025, 4:45pm

Article

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic pancreatic ductal adenocarcinoma.

Honoring a Healer: Personal Care With National Impact

May 7th 2025, 9:00pm

Article

This is a joint nomination by Camille Moses and Dr. Estelamari Rodriguez.

CM24 Combo With Biomarker Targeting Improves Survival in Pancreatic Cancer

April 30th 2025, 4:01pm

Article

CM24 plus Opdivo and chemo improved survival in pancreatic cancer with CEACAM1 biomarkers, supporting a biomarker-driven phase 2b study.